Annoroad

Annoroad Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $105M
Latest Deal Amount
  • Investors
  • 6

Annoroad General Information

Description

Provider of genomic research services intended to be used for clinical testing and life science research. The company's genomic research services include NextSeq 550AR sequencer and Non-Invasive Prenatal Testing (NIPT) reagent kit, helps researchers in next-generation sequencing (NGS) diagnostic applications in the field of human reproduction, cancer and rare diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Building B2, Yard 88, kechuang 6 Road
  • Beijing Economic-Technological Development Area
  • Beijing, 100176
  • China
+86 010 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Annoroad Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series C) 03-Nov-2017 $105M 00000 Completed Generating Revenue
1. Early Stage VC 01-Jan-2014 Completed Generating Revenue

Annoroad Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Novogene Venture Capital-Backed Beijing, China 0000 0000 00000000000 0000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
0000000000 Formerly VC-backed Menlo Park, CA 000 00000 00000000 00000
0000000 Corporation Austin, TX 0000 000.00 00000000 000.00
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0

Annoroad Executive Team (2)

Name Title Board Seat Contact Info
Chongjian Chen Ph.D Co-Founder, Chief Executive Officer & President
Junbin Liang Co-Founder & Chief Operating Officer

Annoroad Investors (6)

To view Annoroad‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ping An Ventures Venture Capital Minority 000 0000 000000 0
SAIF Partners Growth/Expansion Minority 000 0000 000000 0
SB China Venture Capital Venture Capital Minority 000 0000 000000 0
Shenzhen GTJA Investment Group PE/Buyout Minority 000 0000 000000 0
Zhengxuan Investment Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial